// App-Quantinova.ai

217 : Results of a patient survey on feasibility and face validity of outcome measures for intended use in future studies enrolling participants with polymyalgia rheumatica

Researchers

Presenter

  • Max Yates

Principal Investigators

  • Claire E Owen

  • Sara Muller

  • Karly Graham

  • Lorna Neill

  • Helen Twohig

  • Maarten Boers

  • Mar D M Pujades-Rodriguez

  • Susan Goodman

  • Jonathan T L Cheah

  • Christian Dejaco

  • Chetan Mukhtyar

  • Berit Dalsgaard Nielsen

  • Jo Robson

  • Lee S Simon

  • Bev Shae

  • Sarah L Mackie

  • Catherine Hill

Medical Centers

  • Norwich Medical School, University of East Anglia, Norwich, Norfolk, UK

  • Department of Rheumatology, Austin Health, Melbourne, AUSTRALIA

  • Inflammatory Research Programme and Biostatistics Group, Keele University, Keele, UNITED KINGDOM

  • Chair of PMRGCAuk Scotland, PMRGCAuk Scotland, Scotland, UNITED KINGDOM

  • Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, Netherlands

  • Leeds Institute of Health Sciences, University of Leeds, Leeds, UNITED KINGDOM

  • Laboratory Medicine, Hospital for Special Surgery, New York, NY

  • Division of Rheumatology and Immunology, Medical University of Graz, Graz, Austria

  • Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UK

  • Department of Hematology, Aarhus University Hospital, Aarhus, Denmark

  • Department of Rheumatology, University of the West of England, Bristol, UNITED KINGDOM

  • SDG LLC, SDG LLC, Cambridge, MA

  • School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, CANADA

  • Discipline of Medicine, The University of Adelaide, Adelaide, AUSTRALIA

Locations

  • United Kingdom

  • Australia

  • Netherlands

  • United States

  • Austria

  • Denmark

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Autoimmune (AI)

Disease

  • Giant cell arteritis

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

  • Nutritional risk screening

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A